Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia

BACKGROUND: Intimal hyperplasia remains the primary cause of vein graft failure for the 1 million yearly bypass procedures performed using human saphenous vein (HSV) grafts. This response to injury is caused in part by the harvest and preparation of the conduit. The use of Brilliant Blue FCF (FCF) r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Vasc Surg
Päätekijät: Osgood, Michael J., Sexton, Kevin, Voskresensky, Igor, Hocking, Kyle, Song, Jun, Komalavilas, Padmini, Brophy, Colleen, Cheung-Flynn, Joyce
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480606/
https://ncbi.nlm.nih.gov/pubmed/27763268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2015.02.028
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia